Latest

Multiple Sclerosis

·December 15, 2025·7 min read

Tiny Gut Imposters Could Be Driving Multiple Sclerosis

New research reveals that when gut bacteria closely resemble the myelin sheath that protects nerve fibers, the immune system can become confused and attack both — accelerating multiple sclerosis. In mouse experiments, bacteria engineered to mimic myelin triggered faster disease progression by activating aggressive immune cells that infiltrated the nervous system.

Featured Neurology Neuroscience

·October 22, 2025·8 min read

Oral Bacteria May Drive Multiple Sclerosis

Scientists have found that people with multiple sclerosis (MS) have a distinctly imbalanced oral microbiome—marked by a loss of beneficial bacteria and a rise in inflammation-linked microbes. Using advanced genetic and metabolic profiling, researchers revealed that saliva from MS patients also had lower levels of hypotaurine, a molecule that supports antioxidant defense and nerve health.

Featured Neurology Neuroscience

·October 20, 2025·6 min read

First Signs of Multiple Sclerosis Found Years Before Symptoms

Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis. By analyzing over 5,000 blood proteins, they identified molecular signs of damage to myelin—the protective sheath around nerve fibers—long before symptoms emerge.

Featured Neurology Neuroscience

·October 14, 2025·6 min read

Pregnancy Hormones Show Promise in Treating Progressive MS

Researchers have identified two forms of estrogen, estradiol and estriol, that may reduce inflammation and protect nerve fibers in progressive multiple sclerosis (MS). Using a virus model of the disease, the study found that both hormones lowered spinal cord inflammation, while estradiol significantly preserved the myelin sheath that protects nerve cells.

Featured Neurology Neuroscience

·October 10, 2025·7 min read

Inflammatory Brain Cells Driving Progressive MS Discovered

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS). These cells, called disease-associated radial glia-like (DARG) cells, appear six times more often in patients with progressive MS than in healthy individuals.

Featured Neurology Neuroscience

·October 9, 2025·8 min read

Compound Could Repair Nerve Damage in Multiple Sclerosis

Researchers have identified two compounds capable of repairing the protective myelin sheath damaged by multiple sclerosis, a major advance toward reversing nerve injury rather than just slowing it. The lead compound, K102, not only promotes remyelination but also balances immune function—key for long-term neurological recovery.

This shows a person with their signal cord highlighted. In the background are people with various mobility devices.

Featured Neurology Neuroscience

·August 1, 2025·6 min read

Signs of MS Emerge 15 Years Before Diagnosis

A large-scale analysis of health records reveals that subtle signs of multiple sclerosis (MS) may appear more than a decade before diagnosis. People who eventually develop MS began increasing healthcare visits—especially for general symptoms like fatigue, pain, and anxiety—15 years before neurologists identified their first demyelinating event.

This shows a large viral cell and DNA with a researcher analyzing data in the background.

Featured Genetics Neurology Neuroscience

·July 29, 2025·4 min read

DNA Reveals Multiple Sclerosis Risk Before Symptoms Begin

Researchers are launching a groundbreaking study to investigate how genetics and the Epstein-Barr virus may work together to trigger multiple sclerosis (MS). Using a method called "recall by genotype," the team will compare biological traits in people with high and low genetic risk—long before symptoms arise.

Featured Genetics Neurology Neuroscience

·July 12, 2025·5 min read

Gene Key to MS Immune Regulation Discovered

New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies. In a mouse model of multiple sclerosis, loss of Egr-1 led to reduced regulatory T cell activity and heightened inflammation. T

Featured Genetics Neurology Neuroscience

·July 7, 2025·6 min read

Stem Cell Grafts Show Promise in Repairing Myelin in MS

A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for treating progressive multiple sclerosis (MS). Researchers showed that induced neural stem cells matured into myelin-producing oligodendrocytes and safely integrated into damaged regions in a mouse model.

Featured Neurology Neuroscience

·June 16, 2025·5 min read

Mitochondrial Link to Cerebellar Decline in MS

A new study reveals that mitochondrial dysfunction plays a central role in the loss of Purkinje neurons in the cerebellum, contributing to motor impairments in people with multiple sclerosis (MS). Researchers found that inflammation and demyelination in the cerebellum disrupt the mitochondria—key cellular power sources—leading to energy loss, neuron damage, and ataxia.

Featured Neurology Neuroscience

·June 6, 2025·6 min read

Study Links Gut Bacteria to MS Risk and Reveals Key Triggers

A new twin study has identified specific gut bacteria that may contribute to the development of multiple sclerosis (MS), the most common inflammatory disease of the central nervous system. By comparing identical twins where only one has MS, researchers reduced confounding genetic and environmental factors and pinpointed 51 bacterial taxa with different abundances.